| Table 1. Characteristics of included studies | |||
| Author, year | Methods | Participants, period | Findings |
| Nejdet, 2016 | Retrospective cohort study | Women from IVF Swedish clinics, from 2003 to 2012 | Donor oocyte group consisted of 388 patients, 51 with PE (13.14%). In the control group, 1,105/26,696 (4.14%) had PE. OR 9.059 (95% CI:5.518 to 14.874). Weight: 41.31. |
| Van Dorp, 2014 | Retrospective cohort study | Women from the Dutch Perinatal Register, from 1992 to 2009 | Study group consisted of 61 patients with singleton pregnancies. 8 out of 61 had PE (13.11%). The control group had 21/192 (10.94%) cases of PE. OR 1.238 (95% CI:0.502 to 3.053). Weight 12.47. |
| Levron, 2014 | Retrospective cohort study | From 2005 to 2011. | 13 of 139 patients in the donor oocyte group had PE (9.35%). In the autologous oocyte group, 6 of 126 had PE (4.76%). OR 1.988 (95% CI:0.782 to 5.052). Weight 11.67. |
| Malchau, 2013 | Retrospective cohort study | Women from the Danish in vitro fertilization register, from 1995 to 2010. | The donor oocyte group included 215 patients and 21 cases of PE (9.76%). Control group had 316/9.833 (3.21%) with PE. OR 7.551 (95% CI:3.565 to 15.993). Weight 18.03. |
| Stoop, 2012 | Retrospective cohort study | Matched pair-analysis for age, ethnicity, parity and plurality from the Centre for Reproductive Medicine,Brussels. Data obtained from 1999 to 2008. | Donor oocyte had 15 of 148 pregnant women diagnosed with PE (10.13%). Control group had 8 of 148 (5.4%) with PE. OR 1.930 (95% CI:0.825 to 4.515). Weight 14.07. |
| Salha, 1999 | Retrospective cohort study | Women from St. James's University Hospital, Leeds(UK), from 1992 to 1997 | Donor oocyte group had 3 of 22 patients diagnosed with PE (13.63%). In the control group, only 1 pregnant woman of 26 was diagnosed with PE (3.8%). OR 3.508 (95% CI:0.459 to 26.781). Weight 2.46. |